Ellevest, Inc. Paratek Pharmaceuticals, Inc. Transaction History

Ellevest, Inc.

  • $1.66 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 19, 2022
SELL
$2.94 - $4.77 $94 - $152
-32 Closed
0 $0
Q4 2021

Jan 24, 2022
BUY
$4.07 - $5.3 $81 - $106
20 Added 166.67%
32 $0
Q3 2021

Oct 19, 2021
BUY
$4.7 - $7.24 $56 - $86
12 New
12 $0

Others Institutions Holding PRTK

# of Institutions
4
Shares Held
1.54M
Call Options Held
0
Put Options Held
0
View Full List

About Paratek Pharmaceuticals, Inc.

PRTK Quotes by TradingView
  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Ellevest, Inc. Portfolio

Follow Ellevest, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email